NYSEARCA:INFU - US45685K1025 - Common Stock
The current stock price of INFU is 10.16 USD. In the past month the price increased by 35.11%. In the past year, price increased by 73.97%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CVS | CVS HEALTH CORP | 11.64 | 93.58B | ||
CI | THE CIGNA GROUP | 10.87 | 81.50B | ||
LH | LABCORP HOLDINGS INC | 18.41 | 23.16B | ||
DGX | QUEST DIAGNOSTICS INC | 19.4 | 20.52B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 112.76 | 14.78B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 12.2 | 14.54B | ||
HIMS | HIMS & HERS HEALTH INC | 60.51 | 10.94B | ||
DVA | DAVITA INC | 14.23 | 9.86B | ||
GH | GUARDANT HEALTH INC | N/A | 7.50B | ||
CHE | CHEMED CORP | 20.81 | 6.78B | ||
RDNT | RADNET INC | 198.36 | 5.49B | ||
OPCH | OPTION CARE HEALTH INC | 21.55 | 4.72B |
InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 502 full-time employees. The company went IPO on 2006-06-15. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
INFUSYSTEM HOLDINGS INC
3851 West Hamlin Road
Rochester Hills MICHIGAN 48309 US
CEO: Richard DiIorio
Employees: 508
Phone: 12482911210
The current stock price of INFU is 10.16 USD. The price decreased by -4.42% in the last trading session.
The exchange symbol of INFUSYSTEM HOLDINGS INC is INFU and it is listed on the NYSE Arca exchange.
INFU stock is listed on the NYSE Arca exchange.
11 analysts have analysed INFU and the average price target is 12.75 USD. This implies a price increase of 25.49% is expected in the next year compared to the current price of 10.16. Check the INFUSYSTEM HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
INFUSYSTEM HOLDINGS INC (INFU) has a market capitalization of 207.57M USD. This makes INFU a Micro Cap stock.
INFUSYSTEM HOLDINGS INC (INFU) currently has 508 employees.
INFUSYSTEM HOLDINGS INC (INFU) has a support level at 5.92 and a resistance level at 10.79. Check the full technical report for a detailed analysis of INFU support and resistance levels.
The Revenue of INFUSYSTEM HOLDINGS INC (INFU) is expected to grow by 6.09% in the next year. Check the estimates tab for more information on the INFU EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
INFU does not pay a dividend.
INFUSYSTEM HOLDINGS INC (INFU) will report earnings on 2025-11-05, before the market open.
The PE ratio for INFUSYSTEM HOLDINGS INC (INFU) is 44.17. This is based on the reported non-GAAP earnings per share of 0.23 and the current share price of 10.16 USD. Check the full fundamental report for a full analysis of the valuation metrics for INFU.
The outstanding short interest for INFUSYSTEM HOLDINGS INC (INFU) is 0.85% of its float. Check the ownership tab for more information on the INFU short interest.
ChartMill assigns a technical rating of 10 / 10 to INFU. When comparing the yearly performance of all stocks, INFU is one of the better performing stocks in the market, outperforming 94.32% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to INFU. INFU scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
Over the last trailing twelve months INFU reported a non-GAAP Earnings per Share(EPS) of 0.23. The EPS increased by 1816.67% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 3.63% | ||
ROA | 5.03% | ||
ROE | 9.3% | ||
Debt/Equity | 0.48 |
11 analysts have analysed INFU and the average price target is 12.75 USD. This implies a price increase of 25.49% is expected in the next year compared to the current price of 10.16.
For the next year, analysts expect an EPS growth of 160.1% and a revenue growth 6.09% for INFU